Both in Surgical Instruments
LENSAR vs Pulmonx
Over the past year LNSR returned −43.6% and LUNG returned +20.0%; their daily moves had a correlation of 0.09.
LNSR −43.6% LUNG +20.0%Growth of $1, one year, split-adjusted
| Metric | LNSR | LUNG |
|---|---|---|
| Price | $6.90 | $1.98 |
| Market cap | $84.8M | $85.0M |
| Today | +0.29% | +1.02% |
| 1 month | −16.9% | −16.8% |
| 6 months | +17.5% | +67.8% |
| Year to date | −40.7% | −10.4% |
| 1 year | −44.1% | +13.8% |
| Revenue growth (YoY) | +18.4% | −4.6% |
| Gross margin | 59.3% | 78.0% |
| Net margin | 10.7% | −44.3% |
| P/E (TTM) | 5.5× | — |
| Price / sales | 1.4× | 1.0× |
| Net cash | $9.8M | $18.3M |
| Dividend yield | — | — |
| Volatility (60d) | 72.2% | 99.4% |
| Short % of float | 4.2% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).